Our News on Newswise

Newswise: 61dc668664abe_00215473-014.jpg

Modular super-enhancer controls retinal development

Scientists at St. Jude Children’s Research Hospital identified distinct functions for regions of a super-enhancer that controls gene expression during retina formation, calling it a ‘modular’ super-enhancer.
10-Jan-2022 12:25 PM EST Add to Favorites

World Health Organization and St. Jude Children’s Research Hospital to dramatically increase global access to childhood cancer medicines

The Global Platform for Access to Childhood Cancer Medicines, the first of its kind, will provide an uninterrupted supply of quality-assured childhood cancer medicines to low- and middle-income countries. St. Jude is making a six-year, $200 million...
13-Dec-2021 8:45 AM EST Add to Favorites

Newswise: 1638562203797.jpg

Chemoimmunotherapy dramatically improved survival of high-risk neuroblastoma patients

St. Jude Children’s Research Hospital phase II clinical trial results suggest that the monoclonal antibody hu14.18K322A could help change treatment of children with high-risk neuroblastoma.
3-Dec-2021 2:10 PM EST Add to Favorites

Newswise: 1638214516133.jpg

St. Jude researchers are again among the world’s most highly cited scientists

The thirteen scientists were named to the 2021 list of Highly Cited Researchers by the Institute for Scientific Information at Clarivate, reflecting the international reach of St. Jude research.
16-Nov-2021 9:55 AM EST Add to Favorites

Newswise: 1636473244371.jpg

Safety concerns raised for neuroblastoma candidate drug

St. Jude Children’s Research Hospital scientists have identified the primary target of the experimental cancer drug CX-5164, revealing a possible risk for late effects of treatment.
9-Nov-2021 8:00 AM EST Add to Favorites

Together by St. Jude Teaches Children about the COVID-19 Vaccines in New Coloring Book

Following FDA authorization of the COVID-19 vaccine for 5- to 11-year-olds, Together by St. Jude releases a free coloring book that educates children on COVID-19 vaccines.
2-Nov-2021 10:00 AM EDT Add to Favorites

Newswise: 1634837913172.jpg

Cell-free DNA identifies early signs of relapse in pediatric medulloblastoma

Findings from St. Jude Children’s Research Hospital show that cell-free DNA in cerebrospinal fluid can be used to detect measurable residual disease and identify patients at risk of relapse.
21-Oct-2021 11:30 AM EDT Add to Favorites

Newswise: 1634159475525.png

Powered by St. Jude, Together, a Web-Based Patient Education Resource on Childhood Cancer, Plans to Launch in Seven New Languages

Together by St. Jude announces plans to launch in seven new languages, offering trustworthy medical information about pediatric cancer and shared stories of hope to families around the world
18-Oct-2021 10:00 AM EDT Add to Favorites


See All News

Our YouTube Videos

About

The mission of St. Jude Children’s Research Hospital is to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment. Consistent with the vision of our founder Danny Thomas, no child is denied treatment based on race, religion or a family's ability to pay.

Contacts

Summer Freeman
Executive Communications

summer.freeman@stjude.org

901-595-3061

Mary Powers
Senior Science Writer

mary.powers@stjude.org

901-595-4334

Elizabeth Whittington
Executive Communications

elizabeth.whittington@stjude.org

901-595-0218

Freeda Chebab

Freeda.Chehab@STJUDE.ORG

Katy Hobgood
Media Relations Strategist

katy.hobgood@stjude.org

Erin Podolak
Science Writer

erine_podolak@dfci.harvard.edu

617-632-6527

Michael Sheffield
Senior Media Relations Specialist

michael.sheffield@stjude.org

901-595-0221

Twitter

close
0.51936